Real-world experience with the new pulsed solid-state Thulium: YAG laser (Thulio) for endoscopic enucleation of the prostate.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
02 Aug 2024
Historique:
received: 07 05 2024
accepted: 21 06 2024
medline: 2 8 2024
pubmed: 2 8 2024
entrez: 2 8 2024
Statut: epublish

Résumé

The solid-state Thulium laser (Tm: YAG) is a novel alternative to the widely used Holmium laser for endoscopic enucleation of the prostate (EEP) due to its relatively high peak power. The aim of this study was to examine the efficacy and safety of a new pulsed Tm: YAG laser in its first application in humans. Data were retrospectively collected for the first 103 patients who underwent EEP with a new pulsed solid-state Tm: YAG laser (Thulio The mean preoperative prostate volume was 105.6 ± 55.0 ml. Median enucleation speed was 4.1 g per minute (range 1.1-9.7). Short-term postoperative complications occurred in 21 patients (20.4%), but no high-grade complications (CDC ≥ IV) were observed. Five patients suffered gross haematuria and required reintervention (CDC IIIb; 4.9%). After 15 months, 76 patients (73.8%) participated in the follow-up interview, where seven patients (9.2%) reported complications, including two reinterventions for urethral strictures (CDC IIIb; 2.6%). Most patients reported an improvement in continence (54.0%) and urine stream (93.4%), but no difference in erectile function (81.6%). No persistent dysuria was reported. Patient satisfaction with the surgery results was very high (96.1%). Endoscopic enucleation of the prostate with the new pulsed solid-state Tm: YAG laser is a safe and effective option for surgical BPH treatment. German Clinical Trials Register number: DRKS00031676. Registration date: 10 May 2023, retrospectively registered.

Identifiants

pubmed: 39093491
doi: 10.1007/s00345-024-05141-8
pii: 10.1007/s00345-024-05141-8
doi:

Substances chimiques

Thulium 8RKC5ATI4P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

467

Informations de copyright

© 2024. The Author(s).

Références

Pirola GM, Saredi G, Codas Duarte R et al (2018) Holmium laser versus thulium laser enucleation of the prostate: a matched-pair analysis from two centers. Ther Adv Urol 10(8):223–233. https://doi.org/10.1177/1756287218779784
doi: 10.1177/1756287218779784 pubmed: 30034541 pmcid: 6048626
Perri D, Pacchetti A, Morini E et al (2024) Evaluation of the learning curve for Thulium laser enucleation of the prostate in a contemporary cohort. World J Urol 42(1):246. https://doi.org/10.1007/s00345-024-04958-7
doi: 10.1007/s00345-024-04958-7 pubmed: 38643250
Brunckhorst O, Ahmed K, Nehikhare O, Marra G, Challacombe B, Popert R (2015) Evaluation of the learning curve for Holmium Laser Enucleation of the prostate using multiple outcome measures. Urology 86(4):824–829. https://doi.org/10.1016/j.urology.2015.07.021
doi: 10.1016/j.urology.2015.07.021 pubmed: 26254171
Fraundorfer MR, Gilling PJ (1998) Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 33(1):69–72. https://doi.org/10.1159/000019535
doi: 10.1159/000019535 pubmed: 9471043
Gravas S, Gacci M, Gratzke C et al (2023) Summary Paper on the 2023 European Association of Urology Guidelines on the management of non-neurogenic male lower urinary tract symptoms. Eur Urol 84(2):207–222
doi: 10.1016/j.eururo.2023.04.008 pubmed: 37202311
Sandhu JS, Bixler BR, Dahm P et al (2024) Management of lower urinary tract symptoms attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023. J Urol 211(1):11–19. https://doi.org/10.1097/JU.0000000000003698
doi: 10.1097/JU.0000000000003698 pubmed: 37706750
Netsch C, Gross AJ (2019) Thulium laser enucleation of the prostate. Curr Opin Urol 29(3):302–303. https://doi.org/10.1097/MOU.0000000000000610
doi: 10.1097/MOU.0000000000000610 pubmed: 30950888
Socarrás MR, Del Álamo JF, Sancha FG (2023) Long live holmium! Eur Urol Open Sci 48:28–30. https://doi.org/10.1016/j.euros.2022.07.012
doi: 10.1016/j.euros.2022.07.012 pubmed: 36588773
Bozzini G, Maltagliati M, Besana U et al (2021) Holmium laser enucleation of the prostate with virtual Basket mode: faster and better control on bleeding. BMC Urol 21(1):28. https://doi.org/10.1186/s12894-021-00797-5
doi: 10.1186/s12894-021-00797-5 pubmed: 33622326 pmcid: 7903737
Bozzini G, Berti L, Maltagliati M et al (2022) Thulium: YAG vs continuous-wave thulium fiber laser enucleation of the prostate: do potential advantages of thulium fiber lasers translate into relevant clinical differences? World J Urol. https://doi.org/10.1007/s00345-022-04201-1
doi: 10.1007/s00345-022-04201-1 pubmed: 36357602
Kronenberg P, Traxer O (2019) The laser of the future: reality and expectations about the new thulium fiber laser-a systematic review. Transl Androl Urol 8(Suppl 4):S398–S417. https://doi.org/10.21037/tau.2019.08.01
doi: 10.21037/tau.2019.08.01 pubmed: 31656746 pmcid: 6790412
Perri D, Mazzoleni F, Besana U et al (2023) Pulsed-wave vs continuous-wave Thulium Fiber Laser Enucleation of the prostate (ThuFLEP): a comparison of Perioperative outcomes. Urology 178:120–124. https://doi.org/10.1016/j.urology.2023.05.013
doi: 10.1016/j.urology.2023.05.013 pubmed: 37257589
Xiao K-W, Zhou L, He Q et al (2019) Enucleation of the prostate for benign prostatic hyperplasia thulium laser versus holmium laser: a systematic review and meta-analysis. Lasers Med Sci 34(4):815–826. https://doi.org/10.1007/s10103-018-02697-x
doi: 10.1007/s10103-018-02697-x pubmed: 30604345
Meng C, Peng L, Li J, Li Y, Yang J, Wu J (2022) Comparison of enucleation between thulium laser and holmium laser for benign prostatic hyperplasia: a systematic review and meta-analysis. Asian J Surg 45(2):689–697
doi: 10.1016/j.asjsur.2021.07.045 pubmed: 34384678
Hartung FO, Kowalewski KF, von Hardenberg J et al (2022) Holmium Versus Thulium Laser Enucleation of the prostate: a systematic review and Meta-analysis of Randomized controlled trials. Eur Urol Focus 8(2):545–554. https://doi.org/10.1016/j.euf.2021.03.024
doi: 10.1016/j.euf.2021.03.024 pubmed: 33840611
Ventimiglia E, Villa L, Doizi S et al (2021) Laser lithotripsy: the importance of Peak Power and Pulse Modulation. Eur Urol Focus 7(1):22–25. https://doi.org/10.1016/j.euf.2021.01.012
doi: 10.1016/j.euf.2021.01.012 pubmed: 33531287
Huusmann S, Lafos M, Meyenburg I, Muschter R, Teichmann H-O, Herrmann T (2021) Tissue effects of a newly developed diode pumped pulsed Thulium:YAG laser compared to continuous wave Thulium:YAG and pulsed Holmium:YAG laser. World J Urol 39(9):3503–3508. https://doi.org/10.1007/s00345-021-03634-4
doi: 10.1007/s00345-021-03634-4 pubmed: 33728503 pmcid: 8510916
Yilmaz M, Esser J, Kraft L et al (2022) Experimental ex-vivo performance study comparing a novel, pulsed thulium solid-state laser, chopped thulium fibre laser, low and high-power holmium:YAG laser for endoscopic enucleation of the prostate. World J Urol 40(2):601–606. https://doi.org/10.1007/s00345-021-03825-z
doi: 10.1007/s00345-021-03825-z pubmed: 34477954
Kraft L, Yilmaz M, Petzold R, Gratzke C, Suarez-Ibarrola R, Miernik A (2022) Dusting efficiency of a Novel Pulsed Thulium:Yttrium Aluminum Garnet Laser vs a Thulium Fiber laser. J Endourol 36(2):259–265. https://doi.org/10.1089/end.2021.0441
doi: 10.1089/end.2021.0441 pubmed: 34693738
Ventimiglia E, Robesti D, Bevilacqua L et al (2023) What to expect from the novel pulsed thulium:YAG laser? A systematic review of endourological applications. World J Urol 41(11):3301–3308. https://doi.org/10.1007/s00345-023-04580-z
doi: 10.1007/s00345-023-04580-z pubmed: 37682286
Capogrosso P, Fallara G, Pozzi E et al (2022) Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center. Minerva Urol Nephrol 74(4):461–466. https://doi.org/10.23736/S2724-6051.21.04315-9
doi: 10.23736/S2724-6051.21.04315-9 pubmed: 33887894
Miernik A, Schoeb DS (2019) Three horse shoe-like incision holmium laser enucleation of the prostate: first experience with a novel en bloc technique for anatomic transurethral prostatectomy. World J Urol 37(3):523–528. https://doi.org/10.1007/s00345-018-2418-0
doi: 10.1007/s00345-018-2418-0 pubmed: 30039386
Madersbacher S, Sampson N, Culig Z (2019) Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: a Mini-review. Gerontology 65(5):458–464. https://doi.org/10.1159/000496289
doi: 10.1159/000496289 pubmed: 30943489

Auteurs

Maximilian Ferry von Bargen (MF)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Hugstetter Str. 55, 79106, Freiburg, Germany. maximilian.vonbargen@uniklinik-freiburg.de.

M Glienke (M)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Hugstetter Str. 55, 79106, Freiburg, Germany.

S Tonyali (S)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Hugstetter Str. 55, 79106, Freiburg, Germany.
Department of Urology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey.

A Sigle (A)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Hugstetter Str. 55, 79106, Freiburg, Germany.

K Wilhelm (K)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Hugstetter Str. 55, 79106, Freiburg, Germany.

M Schoenthaler (M)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Hugstetter Str. 55, 79106, Freiburg, Germany.

C Gratzke (C)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Hugstetter Str. 55, 79106, Freiburg, Germany.

A Miernik (A)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Hugstetter Str. 55, 79106, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH